insights_auto
Why is ALC up 2,57%?
Dive Deeperchevron_right
ALC:NYSE
Alcon AG
67,83 US$
arrow_upward
+2,57%(+1,70) 1D
67,65 US$
arrow_downward
-0,27% (-0,18)bedtimeAfter hours
Closed: 20 ოქტ, 16:00:08 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
67,39 US$
High
67,91 US$
Low
67,10 US$
Mkt. cap
27,95 მლრდ.
Avg. vol.
1,80 მლნ.
Volume
978,64 ათ.
52-wk high
87,64 US$
52-wk low
61,84 US$
Beta
0,88
Shares outstanding
483,40 მლნ.
No. of employees
25 ათ.
Open
67,39 US$
High
67,91 US$
Low
67,10 US$
Mkt. cap
27,95 მლრდ.
Avg. vol.
1,80 მლნ.
Volume
978,64 ათ.
52-wk high
87,64 US$
52-wk low
61,84 US$
Beta
0,88
Shares outstanding
483,40 მლნ.
No. of employees
25 ათ.
News stories
From web sources and news partners
Investing.com Canada
·
2 საათის წინ
Alcon acquires Neurotech for $550m to expand retina portfolio By Investing.com
Stock Traders Daily
·
4 საათის წინ
Precision Trading with Alcon Inc. (ALC) Risk Zones
ad-hoc-news.de
·
8 საათის წინ
Alcon stock: Alcon reports third-quarter results on November 10, 2026
ad-hoc-news.de
·
16 საათის წინ
FDA approves BRYTLY as BTIG cuts Alcon stock target to USD 74
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEOდავიდ ჯეი ენდიკოტ
Employees25 ათ.
Founded1945
Headquartersჟენევა, ჟენევის კანტონი, შვეიცარია
SectorMedical device
Websitealcon.com